HEADER HYDROLASE 26-FEB-14 4CRC TITLE CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD TITLE 2 GENERATION AND STRUCTURE AIDED DRUG DESIGN COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XI; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 388-625; COMPND 5 SYNONYM: FXI, PLASMA THROMBOPLASTIN ANTECEDENT, PTA, COAGULATION COMPND 6 FACTOR XIA LIGHT CHAIN; COMPND 7 EC: 3.4.21.27; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.SANDMARK,L.OSTER,O.FJELLSTROM,S.AKKAYA,H.G.BEISEL,P.O.ERIKSSON, AUTHOR 2 K.ERIXON,D.GUSTAFSSON,U.JURVA,D.KANG,D.KARIS,W.KNECHT,V.NERME, AUTHOR 3 I.NILSSON,T.OLSSON,A.REDZIC,R.ROTH,A.TIGERSTROM REVDAT 2 19-AUG-15 4CRC 1 SCALE1 SCALE2 SCALE3 REVDAT 1 11-FEB-15 4CRC 0 JRNL AUTH O.FJELLSTROM,S.AKKAYA,H.BEISEL,P.ERIKSSON,K.ERIXON, JRNL AUTH 2 D.GUSTAFSSON,U.JURVA,D.KANG,D.KARIS,W.KNECHT,V.NERME, JRNL AUTH 3 I.NILSSON,T.OLSSON,A.REDZIC,R.ROTH,J.SANDMARK,A.TIGERSTROM, JRNL AUTH 4 L.OSTER JRNL TITL CREATING NOVEL ACTIVATED FACTOR XI INHIBITORS THROUGH JRNL TITL 2 FRAGMENT BASED LEAD GENERATION AND STRUCTURE AIDED DRUG JRNL TITL 3 DESIGN. JRNL REF PLOS ONE V. 10 13705 2015 JRNL REFN ISSN 1932-6203 JRNL PMID 25629509 JRNL DOI 10.1371/JOURNAL.PONE.0113705 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.6 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.7 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 33253 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1752 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 REFLECTION IN BIN (WORKING SET) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE SET COUNT : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1918 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 195 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4CRC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-14. REMARK 100 THE PDBE ID CODE IS EBI-59830. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35732 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.60 REMARK 200 RESOLUTION RANGE LOW (A) : 41.60 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.0 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.0 REMARK 200 R MERGE FOR SHELL (I) : 0.66 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M AMMONIUM SULFATE, 0.1M REMARK 280 TRIS-CL PH 8.5, 0.2M NACL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z,-X,-Y REMARK 290 7555 -Z,-X,Y REMARK 290 8555 -Z,X,-Y REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z,-X REMARK 290 11555 Y,-Z,-X REMARK 290 12555 -Y,-Z,X REMARK 290 13555 X+1/2,Y+1/2,Z+1/2 REMARK 290 14555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 15555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 16555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 17555 Z+1/2,X+1/2,Y+1/2 REMARK 290 18555 Z+1/2,-X+1/2,-Y+1/2 REMARK 290 19555 -Z+1/2,-X+1/2,Y+1/2 REMARK 290 20555 -Z+1/2,X+1/2,-Y+1/2 REMARK 290 21555 Y+1/2,Z+1/2,X+1/2 REMARK 290 22555 -Y+1/2,Z+1/2,-X+1/2 REMARK 290 23555 Y+1/2,-Z+1/2,-X+1/2 REMARK 290 24555 -Y+1/2,-Z+1/2,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 60.49500 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 60.49500 REMARK 290 SMTRY1 14 -1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 60.49500 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 60.49500 REMARK 290 SMTRY1 15 -1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY2 15 0.000000 1.000000 0.000000 60.49500 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 60.49500 REMARK 290 SMTRY1 16 1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY2 16 0.000000 -1.000000 0.000000 60.49500 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 60.49500 REMARK 290 SMTRY1 17 0.000000 0.000000 1.000000 60.49500 REMARK 290 SMTRY2 17 1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY3 17 0.000000 1.000000 0.000000 60.49500 REMARK 290 SMTRY1 18 0.000000 0.000000 1.000000 60.49500 REMARK 290 SMTRY2 18 -1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY3 18 0.000000 -1.000000 0.000000 60.49500 REMARK 290 SMTRY1 19 0.000000 0.000000 -1.000000 60.49500 REMARK 290 SMTRY2 19 -1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY3 19 0.000000 1.000000 0.000000 60.49500 REMARK 290 SMTRY1 20 0.000000 0.000000 -1.000000 60.49500 REMARK 290 SMTRY2 20 1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY3 20 0.000000 -1.000000 0.000000 60.49500 REMARK 290 SMTRY1 21 0.000000 1.000000 0.000000 60.49500 REMARK 290 SMTRY2 21 0.000000 0.000000 1.000000 60.49500 REMARK 290 SMTRY3 21 1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY1 22 0.000000 -1.000000 0.000000 60.49500 REMARK 290 SMTRY2 22 0.000000 0.000000 1.000000 60.49500 REMARK 290 SMTRY3 22 -1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY1 23 0.000000 1.000000 0.000000 60.49500 REMARK 290 SMTRY2 23 0.000000 0.000000 -1.000000 60.49500 REMARK 290 SMTRY3 23 -1.000000 0.000000 0.000000 60.49500 REMARK 290 SMTRY1 24 0.000000 -1.000000 0.000000 60.49500 REMARK 290 SMTRY2 24 0.000000 0.000000 -1.000000 60.49500 REMARK 290 SMTRY3 24 1.000000 0.000000 0.000000 60.49500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 O1 SO4 A1246 LIES ON A SPECIAL POSITION. REMARK 375 S SO4 A1246 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 245 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 107 O HOH A 2073 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 N ASP A 116 O HOH A 2085 20454 2.10 REMARK 500 CA ASP A 116 O HOH A 2085 20454 1.59 REMARK 500 C ASP A 116 O HOH A 2085 20454 2.18 REMARK 500 CB ASP A 116 O HOH A 2085 20454 1.15 REMARK 500 CD1A LEU A 146 O HOH A 2071 23444 1.52 REMARK 500 CD2B LEU A 146 O HOH A 2071 23444 1.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 148 -148.98 -165.58 REMARK 500 SER A 214 -67.23 -123.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (2S)-2-[[(E)-3-[5-CHLORANYL-2-(1,2,3,4- REMARK 630 TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL]AMINO]-3-PHENYL-PROPANAMIDE REMARK 630 REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 OTM A 1245 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: E29 PHE E30 REMARK 630 DETAILS: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OTM A1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1246 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CR5 RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CR9 RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CRA RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CRB RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CRD RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CRE RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CRF RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 900 RELATED ID: 4CRG RELATED DB: PDB REMARK 900 CREATING NOVEL F1 INHIBITORS THROUGH FRAGMENT BASED LEAD REMARK 900 GENERATION AND STRUCTURE AIDED DRUG DESIGN REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTANT, S75A K78A T97A C123S DBREF 4CRC A 16 245 UNP P03951 FA11_HUMAN 388 625 SEQADV 4CRC ALA A 75 UNP P03951 SER 452 ENGINEERED MUTATION SEQADV 4CRC ALA A 78 UNP P03951 LYS 455 ENGINEERED MUTATION SEQADV 4CRC ALA A 115 UNP P03951 THR 493 ENGINEERED MUTATION SEQADV 4CRC SER A 123 UNP P03951 CYS 500 ENGINEERED MUTATION SEQADV 4CRC GLU A 129 UNP P03951 ASP 506 CONFLICT SEQRES 1 A 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 A 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 A 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 A 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 A 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN ALA SEQRES 6 A 238 GLU ILE ALA GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 A 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 A 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN SEQRES 9 A 238 TYR ALA ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS SEQRES 10 A 238 GLY GLU ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 A 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 A 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 A 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 A 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 A 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 A 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 A 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 A 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 A 238 THR GLN ALA VAL HET OTM A1245 39 HET SO4 A1246 5 HETNAM OTM (2S)-2-[[(E)-3-[5-CHLORANYL-2-(1,2,3,4- HETNAM 2 OTM TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL]AMINO]-3-PHENYL- HETNAM 3 OTM N-[4-(1H-1,2,3,4-TETRAZOL-5-YL)PHENYL] HETNAM 4 OTM PROPANAMIDE HETNAM SO4 SULFATE ION FORMUL 2 OTM C26 H21 CL N10 O2 FORMUL 3 SO4 O4 S 2- FORMUL 4 HOH *195(H2 O) HELIX 1 1 ALA A 55 TYR A 59A 5 6 HELIX 2 2 SER A 61 LYS A 63 5 3 HELIX 3 3 GLN A 74 ILE A 77 5 4 HELIX 4 4 MET A 96 GLY A 100 5 5 HELIX 5 5 SER A 126 ARG A 130 5 5 HELIX 6 6 THR A 164 TYR A 172 1 9 HELIX 7 7 TYR A 234 ALA A 244 1 11 SHEET 1 AA 8 THR A 20 ALA A 21 0 SHEET 2 AA 8 GLN A 156 LYS A 159 -1 O LYS A 157 N THR A 20 SHEET 3 AA 8 CYS A 136 GLY A 140 -1 O VAL A 138 N ALA A 158 SHEET 4 AA 8 PRO A 198 HIS A 202A-1 O PRO A 198 N THR A 139 SHEET 5 AA 8 VAL A 202D TRP A 215 -1 O VAL A 202D N HIS A 202A SHEET 6 AA 8 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 AA 8 MET A 180 ALA A 183 -1 O ILE A 181 N TYR A 228 SHEET 8 AA 8 LEU A 162 VAL A 163 -1 O VAL A 163 N CYS A 182 SHEET 1 AB 7 GLN A 30 THR A 35 0 SHEET 2 AB 7 ARG A 37D GLY A 46 -1 O ARG A 37D N THR A 35 SHEET 3 AB 7 TRP A 51 THR A 54 -1 O TRP A 51 N ILE A 45 SHEET 4 AB 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 AB 7 PHE A 83 ILE A 90 -1 N GLN A 86 O LYS A 107 SHEET 6 AB 7 LEU A 65 TYR A 68 -1 O LEU A 65 N VAL A 85 SHEET 7 AB 7 GLN A 30 THR A 35 -1 O THR A 32 N TYR A 68 SSBOND 1 CYS A 40 CYS A 58 1555 1555 2.01 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.05 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.03 CISPEP 1 SER A 37 PRO A 37A 0 -4.05 SITE 1 AC1 24 LEU A 39 HIS A 57 TYR A 114 TYR A 143 SITE 2 AC1 24 ILE A 151 ASP A 189 ALA A 190 CYS A 191 SITE 3 AC1 24 LYS A 192 GLY A 193 ASP A 194 SER A 195 SITE 4 AC1 24 TRP A 215 GLY A 216 GLY A 218 CYS A 219 SITE 5 AC1 24 GLY A 226 VAL A 227 HOH A2029 HOH A2032 SITE 6 AC1 24 HOH A2136 HOH A2177 HOH A2179 HOH A2195 SITE 1 AC2 2 LYS A 127 ARG A 130 CRYST1 117.760 117.760 117.760 90.00 90.00 90.00 I 2 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008492 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008492 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008492 0.00000